PATENT CLAIM ANALYSIS

Application Number: 16302158
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["514", "210180"]

Abstract:
The present invention provides compounds of Formula (I): as defined in the specification and compositions comprising any of such novel compounds. These compounds are endothelial lipase inhibitors which may be used as medicament.

Claim (Index 13):
The compound according to  claim 9 , wherein\n R 6  is, independently at each occurrence, selected from: OH, halogen, C 1-6  alkyl, C 1-4  alkoxy, C 1-4  haloalkyl, C 1-4  haloalkoxy, NH 2 , NHR g , OPh, OBn, Ph, \u2014CONH 2 , \u2014CONHR i ; and \u2014CONR h R i ; or alternatively, two R 6 , taken together with the atoms to which they are attached, form pyrrolidinonyl or pyridinonyl; each of which is substituted with 0, 1, or 2 R 8 ; R g  is C 1-4  alkyl, CO 2 R m , or CONHR p ; R i  is C 1-4  alkyl, C 1-4  alkoxy, C 1-4  haloalkyl, C 1-4  haloalkoxy; or alternatively, R h  and R, taken together with the atoms to which they are attached, form azetidinyl, pyrrolidinyl, piperidinyl, morpholinyl, or piperazinyl, each of which is substituted with 0, 1, or 2 R 9 ; R m  and R p  are independently C 1-4  alkyl, C 1-4  alkoxy, C 1-4  haloalkyl, or C 1-4  haloalkoxy; and Q is 0.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 98.0
- Lexical Diversity: 1.15152
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13936311', '13944921', '14427105', '14346745', '14390152']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7662466629412775
- 35 USC 102 Novelty (BERT): 0.526257514690111
- Combined Prediction Score: 0.7422477481161608
- Mean Citation Score: 302.8511640000001
- Max Citation Score: 311.87286
- Similarity Product: 224.4539612856102

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test